iRhythm (IRTC) vs UFP Technologies (UFPT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
UFP Technologies (UFPT) has outperformed iRhythm (IRTC) over the past year, gaining 50.1% versus a loss of 39.6%. Over five years, UFPT leads with a +352.8% price change compared with +47.6% for IRTC. iRhythm is the larger company by market cap ($3.52 billion vs $2.24 billion), about 1.6 times the size.
On valuation, UFP Technologies trades at a lower forward P/E (24.3x vs 83.3x for iRhythm). UFP Technologies converts more of its revenue into profit, with a net margin of 11.3% versus -6.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IRTC | UFPT |
|---|---|---|
| Share price | $106.70 | $288.97 |
| Market cap | $3.52B | $2.24B |
| 1-day change | +4.00% | +0.84% |
| YTD return | -39.87% | +30.15% |
| 1-year return | -39.57% | +50.09% |
| 5-year return | +47.60% | +352.79% |
| P/E ratio (TTM) | — | 31.21 |
| Forward P/E | 83.26 | 24.34 |
| EPS (TTM) | $-0.42 | $9.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $747.14M | $602.80M |
| Revenue growth (YoY) | +26.24% | +19.50% |
| Net income (latest FY) | $-44.55M | $68.31M |
| Gross margin | 70.57% | 28.27% |
| Operating margin | -7.68% | 15.32% |
| Net margin | -5.96% | 11.33% |
| 52-week high | $212.00 | $338.71 |
| 52-week low | $100.70 | $173.86 |
| Distance from 52-week high | -49.67% | -14.69% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +63.01% | +22.85% |
| Average volume | 569.39K | 152.09K |
| Shares outstanding | 32.96M | 7.75M |
| Employees | 2,400 | 4,846 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- UFPT has outperformed IRTC by 89.7 percentage points over the past year.
- UFP Technologies is more profitable, keeping 11.3 cents of every revenue dollar as net income versus -6.0 cents for iRhythm.
- iRhythm grew revenue faster in its latest fiscal year (+26.24% vs +19.50%).
About iRhythm
IRTC stock →iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.
Health Care · Medical/Dental Instruments · 2,400 employees
About UFP Technologies
UFPT stock →UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing.
Health Care · Medical/Dental Instruments · 4,846 employees
IRTC vs UFPT FAQ
Which is bigger, iRhythm or UFP Technologies?
iRhythm (IRTC) is larger, with a market capitalization of $3.52B compared with $2.24B for UFP Technologies (UFPT).
Which stock has performed better over the past year, IRTC or UFPT?
UFPT returned +50.09% over the past 12 months, compared with -39.57% for IRTC (price return, excluding dividends). Past performance does not predict future results.
Are iRhythm and UFP Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.